Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma

BACKGROUND: Although sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced HCC....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Lee, Sangheun, Kim, Beom Kyung, Kim, Seung Up, Park, Yehyun, Chang, Sooyun, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Chon, Chae Yoon, Han, Kwang-Hyub
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3796498/
https://ncbi.nlm.nih.gov/pubmed/24155932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077240
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki